References
- Barbisan G, Perez LO, Contreras A, Golijow CD. (2012). TNF-α and IL-10 promoter polymorphisms, HPV infection, and cervical cancer risk. Tumour Biol 33:1549–56
- Chae SC, Li CS, Kim KM, et al. (2007). Identification of polymorphisms in human interleukin-27 and their association with asthma in a Korean population. J Hum Genet 52:355–61
- Ho MY, Leu SJ, Sun GH, et al. (2009). Il-27 directly restrains lung tumorigenicity by suppressing cyclooxygenase-2-mediated activities. J Immunol 183:6217–26
- Hu P, Hu HD, Chen M, et al. (2009). Expression of interleukins-23 and 27 leads to successful gene therapy of hepatocellular carcinoma. Mol Immunol. 46:1654–62
- Huang ZQ, Wang JL, Pan GG, Wei YS. (2012). Association of single nucleotide polymorphisms in Il-12 and Il-27 genes with colorectal cancer risk. Clin Biochem 45:54–9
- Hunter CA. (2005). New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol 5:521–31
- Ibeanu OA. (2011). Molecular pathogenesis of cervical cancer. Cancer Biol Ther. 11:295–306
- Katki HA, Kinney WK, Fetterman B, et al. (2011). Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncol 12:663–72
- Li CS, Zhang Q, Lee KJ, et al. (2009). Interleukin-27 polymorphisms are associated with inflammatory bowel diseases in a Korean population. J Gastroenterol Hepatol 24:1692–6
- Liu D, Zhou P, Zhang L, et al. (2011). Differential expression of oct4 in hpv-positive and hpv-negative cervical cancer cells is not regulated by DNA methyltransferase 3a. Tumour Biol 32:941–50
- Miyazaki Y, Inoue H, Matsumura M, et al. (2005). Exacerbation of experimental allergic asthma by augmented Th2 responses in WSX-1-deficient mice. J Immunol 175:2401–7
- Owaki T, Asakawa M, Fukai F, et al. (2006). IL-27 induces Th1 differentiation via p38 MAPK/T-bet- and intercellular adhesion molecule-1/LFA-1/ERK1/2-dependent pathways. J Immunol 177:7579–87
- Peng Q, Qin X, He Y, et al. (2013). Association of Il27 gene polymorphisms and HBV-related hepatocellular carcinoma risk in a Chinese population. Infect Genet Evol 16:1–4
- Schiffman M, Castle PE, Jeronimo J, et al. (2007). Human papillomavirus and cervical cancer. Lancet 370:890–907
- Tao YP, Wang WL, Li SY, et al. (2012). Associations between polymorphisms in Il-12a, Il-12b, Il-12rbeta, 1, Il–27 gene and serum levels of Il-12p40, Il-27p28 with esophageal cancer. J Cancer Res Clin Oncol 138:1891–900
- Torre LA, Bray F, Siegel RL, et al. (2015). Global cancer statistics, 2012. CA: Cancer J Clin 65:87–108
- Trinchieri G, Pflanz S, Kastelein RA. (2003). The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 19:641–4
- Wei YS, Lan Y, Luo B, et al. (2009). Association of variants in the interleukin-27 and interleukin-12 gene with nasopharyngeal carcinoma. Mol Carcinog 48:751–7
- Yoshimoto T, Morishima N, Mizoguchi I, et al. (2008). Antiproliferative activity of Il-27 on melanoma. J Immunol 180:6527–35
- Zhang S, Wang Y, Wang M, Ji Z. (2014). Il-27 -964A>G polymorphism and the risk of breast cancer: a case-control study. Tumour Biol 35:12099–102